Who is sponsoring NCT07587957?

NCT07587957 is sponsored by Florida Atlantic University.

What drugs are being tested in NCT07587957?

Interventions in NCT07587957: Exercise + transcranial alternating current stimulation (Ex+tACS), Control.

What condition does NCT07587957 study?

NCT07587957 studies Breast Cancer.

Is NCT07587957 still recruiting?

NCT07587957 is currently recruiting now.

Last reviewed 2026-06-10 · How we verify

NCT07587957

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Exploring the Feasibility of an Exercise and Noninvasive Brain Stimulation Intervention in Breast Cancer Survivors

Recruiting now NA

What this trial tests

NA trial testing Exercise + transcranial alternating current stimulation (Ex+tACS) in Breast Cancer in 40 participants. Currently enrolling.

Timeline

7 January 2026

1 January 2027

Quick facts

Lead sponsor	Florida Atlantic University
Phase	NA
Status	Recruiting now
Enrollment	40
Start date	7 January 2026
Estimated completion	1 January 2027

Drugs / interventions tested

Exercise + transcranial alternating current stimulation (Ex+tACS)
Control

Conditions studied

Breast Cancer — all drugs for Breast Cancer →

Sponsor

Florida Atlantic University

Who can join

Eligibility, any sex, with Breast Cancer.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Breast Cancer

Currently open trials in the same condition.

NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
NCT07405801 — A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus R · Phase 2 · recruiting
NCT07285993 — Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET · Phase 2 · recruiting
NCT07510698 — Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer · NA · recruiting
NCT06768931 — Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer · Phase 2 · recruiting

Other Florida Atlantic University trials

Trials by the same sponsor.

NCT06645548 — Machine Learning and 3D Image-Based Modeling for Real-Time Body Weight and Body Composition Estimation During Emergency · NA · withdrawn
NCT06646133 — Machine Learning and 3D Image-Based Modeling for Real-Time Body Weight and Body Composition Estimation During Emergency · withdrawn
NCT07127510 — Brain NAD in Alzheimer's Disease · recruiting
NCT07216846 — The Geriatric Emergency Department Pharmacologic Harm Prevention Project · NA · recruiting
NCT06910241 — Lidocaine Versus Diphenhydramine to Achieve Local Anesthesia for Laceration Repairs · Phase 3 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07587957 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Florida Atlantic University
Last refreshed: recently

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07587957.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing